Akoya Biosciences, Inc.
(NASDAQ GS: AKYA)
Rigrodsky Law, P.A. is investigating Akoya Biosciences, Inc. (“Akoya”) regarding possible breaches of fiduciary duties and other violations of law related to Akoya’s agreement to be acquired by Quanterix Corporation (“Quanterix”). Under the terms of the agreement, Akoya shareholders will receive 0.318 shares of Quanterix common stock for each share of Akoya common stock owned.